Toward Self-management in ILD
Toward a Model of Self-management; Identifying Gaps and Needs in Services for Patients With Interstitial Lung Disease
1 other identifier
observational
16
1 country
2
Brief Summary
Treating and caring for people with long term conditions accounts for a substantial proportion of health care resources. Self-management is advocated as a mechanism that can empower service users with long term conditions to choose healthier options and also transform the relationship between service user and caregivers from one in which the former is a passive recipient of care to one in which they are an active partner in decision-making. Interstitial lung disease (ILD) is one such long term condition. Patients with ILD often express concern about the lack of information on possible rehabilitation programmes and other services that could potentially improve self-management of the disease. In addition, there is a general perception about a lack of co-ordination between health care professionals especially in relation to referral to services for comprehensive management of the disease. Therefore, the needs of patients with ILD and their carers, and possible gaps in service provision need to be explored further. In this study, the investigators propose to explore the needs of ILD patients from all types of ILD and all stages of severity and to also involve carers and clinicians. The investigators will conduct three focus groups for patients and carers and six one-to-one interviews with clinicians to explore perceptions about service gaps and needs in two ILD centres in South and North London, UK. This study will provide valuable information to develop the building blocks of a self-management resource and will enable the investigators to make it specific to the different types of ILD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2018
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2017
CompletedFirst Posted
Study publicly available on registry
October 3, 2017
CompletedStudy Start
First participant enrolled
June 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedFebruary 21, 2021
February 1, 2021
2.4 years
September 28, 2017
February 18, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Perceptions of service needs and gaps in current services among ILD patients, carers and clinicians
Exploratory method, conducted using semi-structured 1:1 interviews and focus groups
1-2 hours
Secondary Outcomes (4)
Differences in perceptions between participating ILD patients, carers and clinicians
1-2 hours
Presentation and explanation of diagnosis and its implications to ILD patients and carers
1-2 hours
Presentation and explanation of information about the management of the disease to ILD patients and carers
1-2 hours
Recommended solutions for better self-management
1-2 hours
Study Arms (3)
ILD patients
Patients from all types of ILD who are under the care of the two collaborating hospitals.
Family/Carers
Family and carers of patients with ILD who are or have been treated in the two collaborating hospitals.
Clinicians
Clinicians from the two collaborating hospitals and GPs from the nearby areas who treat and refer patients with ILD.
Interventions
Focus group discussion led by the PI and facilitated by another researcher.
Eligibility Criteria
Patients with Interstitial Lung disease (ILD), their carers and healthcare professionals involved in their care in two hospitals in South and North London, UK.
You may qualify if:
- Diagnosed with Interstitial Lung disease (all types apart from sarcoidosis)
- Age \>18 years
- At least one consultation with a health care professional
You may not qualify if:
- Diagnosed with sarcoidosis
- Unable to communicate in English
- Severity of condition and commodities preventing participation
- CAREGIVERS
- \- Currently caring for a participant with ILD
- \- Unable to communicate in English
- CLINICIANS:
- \- Involved in the clinical management and treatment of ILD patients
- \- Health care professionals not directly involved in management or treatment of ILD patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kingston Universitylead
- St. George's Hospital, Londoncollaborator
- University College London Hospitalscollaborator
Study Sites (2)
St George's Hospital London
London, SW17 ORE, United Kingdom
University College Hospital
London, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dimitra Nikoletou, PhD
Kingston University and St George's University of London- Joint Faculty- Health, Social care and Education
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 28, 2017
First Posted
October 3, 2017
Study Start
June 1, 2018
Primary Completion
October 30, 2020
Study Completion
December 30, 2020
Last Updated
February 21, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share
A unique identification number will be allocated to each participant and data will not be shared without being anonymised